BIOVENTUS INC. — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$568M
Cost of Revenue
$180M
Gross Profit
$388M
R&D
$12M
SG&A
$314M
D&A
$47M
Operating Income
$54M
EBITDA
$101M
Interest Expense
$-26M
Other Income/Expense
$-55M
Pretax Income
$26M
Tax Provision
$-2M
Net Income
$23M
Gross Margin
68.3%
Operating Margin
9.5%
Net Margin
4.0%
Effective Tax Rate
-6.1%
Deferred Tax Assets
$6M
Deferred Tax Liabilities
$433K
DTA Valuation Allowance
$48M
Tax Credit Carryforwards
$3M
NOL Carryforwards
$10M
ETR (Continuing Operations)
-6.1%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
1.0%
ETR Foreign Differential (pp)
-0.6%
Operating Lease Cost
$3M
Revenue YoY Variation
-0.9%
Income YoY Variation
455.2%